News
[Closed] EUnetHTA 21 launches Open Call for JSC
EUnetHTA 21 is launching the first Open Call for applications from the pharmaceutical industry for four Joint Scientific Consultations (JSC), starting in January 2022. These
EUnetHTA 21 – first Stakeholder Kick-Off Meeting
EUnetHTA 21 Secretariat is pleased to announced that the first EUnetHTA 21 Stakeholder Kick-Off Meeting is scheduled, online, for 03.12.2021 at 10:30-12:00 CET. The meeting will entail a high-level focus
EUnetHTA 21 JSC – open calls
As one of the first milestones of EUnetHTA 21, we will soon launch the first open call to pharmaceutical industry for applications for the upcoming
European HTA agencies launch the Heads of Agencies Group (HAG)
On 29 September 2021, the heads of 19 European HTA agencies came together and inaugurated a new HTA-focused collaborative network for high-level strategic exchange and
EUnetHTA 21
On 17 September 2021, the European Health and Digital Executive Agency (HaDEA) signed the Service Contract for the Provision of Joint Health Technology Assessment (HTA) Work
Future Model of Cooperation (FMC) – White Paper
EUnetHTA has become synonymous with HTA in Europe, a trademark, in fact, that stands for a community of professionals dedicated to continuously improve the standards
OTCA26 Obesity Surgery Project – Final Assessment now available
The final report is now available for the Relative Effectiveness Assessment OTCA26 “Surgical procedures for treatment of obesity”. The aim of this multi-technology HTA was
EUnetHTA Magazine Summer 2021 – now available
We are pleased to publish the EUnetHTA Magazine for Summer 2021, the last issue of Joint Action 3 (2016-2021). While the magazine is intended to
PTJA16 – Venetoclax in combination with an hypomethylating agent for treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy – final assessment now available
This is the pharmaceutical Joint Assessment PTJA16 – Venetoclax with a hypomethylating agent fort he treatment of adult patients with newly diagnosed acute myeloid leukaemia
EUnetHTA and EMA take stock of their cooperation
The European Network for Health Technology Assessment (EUnetHTA) and the European Medicines Agency (EMA) have published a Technical Report on their achievements since 2017.
